FindTrial
Sign In

The role and mechanism of Gpr124 in promoting PDR neovascularization by regulating endothelial cells

The role and mechanism of Gpr124 in promoting PDR neovascularization by regulating endothelial cells

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300075556
Enrollment
Unknown
Registered
2023-09-08
Start date
2023-09-08
Completion date
Unknown
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic retinopathy

Interventions

Proliferative diabetic retinopathy:None

Sponsors

Second Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Both men and women, aged 20-90, agree to participate in this study and sign an informed consent form; 2. Patients diagnosed with PDR after examination and requiring surgical treatment.

Exclusion criteria

Exclusion criteria: 1. People with other fundus diseases except diabetes retinopathy, such as glaucoma, retinal vein occlusion, age-related macular degeneration, etc; 2. Patients with previous endophthalmitis; 3. Patients with a history of intraocular surgery; 4. Patients who have previously undergone intraocular injection.

Design outcomes

Primary

MeasureTime frame
Changes in the expression of GPR124;—

Countries

China

Contacts

Public ContactYuan Rongdi

Second Affiliated Hospital of Army Medical University

1253450264@qq.com+86 132 2868 7341

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026